Initial Treatment for Esophagitis
The initial treatment for esophagitis should be proton pump inhibitors (PPIs) administered twice daily for 8-12 weeks, with omeprazole 20mg twice daily being the recommended first-line therapy. 1, 2
Types of Esophagitis and First-Line Treatment
Erosive Esophagitis
- Initial therapy: PPI twice daily for 4-8 weeks 2, 3
- Duration: 4-8 weeks initially, with assessment of response 3
- Efficacy: PPIs heal erosive esophagitis in 80-90% of cases 4
- Symptom resolution: Dysphagia resolves in approximately 83% of patients after 4 weeks of PPI treatment 4
Eosinophilic Esophagitis (EoE)
- Initial therapy: PPI twice daily for 8-12 weeks 2, 1
- Response rate: Approximately 41.7% of EoE patients respond to PPI therapy 1
- Assessment: Endoscopy with biopsy while on treatment is required to evaluate response 1
- Remission definition: <15 eosinophils/0.3 mm² on histology 1
Treatment Algorithm
Start with PPI therapy:
Assess response after 4-8 weeks:
If inadequate response to standard-dose PPI:
For refractory eosinophilic esophagitis:
Important Considerations
- Medication timing: PPIs should be taken 30-60 minutes before meals for optimal efficacy 2
- Maintenance therapy: Long-term use of PPIs is recommended for patients with esophagitis once proven clinically effective 2
- Dose titration: Maintenance therapy should be titrated to the lowest effective dose based on symptom control 2
- Continuous vs. on-demand: Continuous therapy is recommended for patients with a history of erosive esophagitis; on-demand therapy is not recommended 2
Common Pitfalls and Caveats
- Persistent dysphagia: If dysphagia persists after 4 weeks of PPI therapy, it may indicate failed healing and warrants further investigation 4
- Relapse rates: Erosive esophagitis has a high relapse rate (up to 82% within 6 months) when treatment is stopped 7
- Severity assessment: The severity of dysphagia is not a reliable predictor of the severity of erosive esophagitis 4
- PPI-responsive EoE: Approximately 23% of patients initially diagnosed with EoE will respond to PPI therapy and should be reclassified as PPI-responsive esophageal eosinophilia 6
- Endoscopic follow-up: For eosinophilic esophagitis, endoscopy with biopsy is necessary to confirm histological response, as symptoms may not correlate with histological activity 1
By following this treatment approach, most patients with esophagitis will experience significant improvement in both symptoms and mucosal healing, leading to improved quality of life and reduced risk of complications.